Novo Nordisk A/S (NVO)
NYSE: NVO
· Real-Time Price · USD
74.37
-2.65 (-3.44%)
At close: Jun 17, 2025, 3:59 PM
74.07
-0.40%
After-hours: Jun 17, 2025, 07:59 PM EDT
-3.44% (1D)
| Bid | 74.02 |
| Market Cap | 332.27B |
| Revenue (ttm) | 303.14B |
| Net Income (ttm) | 104.61B |
| EPS (ttm) | 3.62 |
| PE Ratio (ttm) | 20.54 |
| Forward PE | 2.34 |
| Analyst | Buy |
| Ask | 74.32 |
| Volume | 7,711,806 |
| Avg. Volume (20D) | 10,054,988 |
| Open | 75.51 |
| Previous Close | 77.02 |
| Day's Range | 74.14 - 75.78 |
| 52-Week Range | 57.00 - 148.15 |
| Beta | 0.22 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NVO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 days ago
+2.95%
Novo Nordisk shares are trading higher after the c...
Unlock content with
Pro Subscription
1 week ago
+5.13%
Novo Nordisk shares are trading higher. The company announced it will present data from the STEP UP trial on the higher dose if Wegovy at the American Diabetes Association 85th Scientific Sessions.
